Report of the 6th International Workshop on PET in lymphoma.
Identifieur interne : 000442 ( PubMed/Corpus ); précédent : 000441; suivant : 000443Report of the 6th International Workshop on PET in lymphoma.
Auteurs : Cristina Nanni ; Anne Ségolène Cottereau ; Egesta Lopci ; Caroline Bodet-Milin ; Monica Coronado ; Barbara Pro ; Wong Seog Kim ; Judith Trotman ; Sally Barrington ; Ulrich Duhrsen ; Thierry Vander Borght ; Elena Zamagni ; Françoise Kraeber-Bodéré ; Christina Messiou ; Alain Rahmouni ; Irène Buvat ; Marc Andre ; Mark Hertzberg ; Wim Oyen ; Olivier Casasnovas ; Stefano Luminari ; Laurent Garderet ; Françoise Montravers ; Carsten Kobe ; Regine Kluge ; Annibale Versari ; Emanuele Zucca ; Philippe Moreau ; Bruce Cheson ; Corinne Haioun ; Andrea Gallamini ; Michel MeignanSource :
- Leukemia & lymphoma [ 1029-2403 ] ; 2017.
Abstract
Two hundred and ten nuclear medicine physicians, radiologists, and hematologists from 26 countries attended the 6th International Workshop on Positron Emission Tomography (PET) in Lymphoma and Myeloma held in Menton, France, in September 2016. The meeting was under the auspices of the European Lymphoma Institute (ELI), the European Association of Nuclear Medicine (EANM) the Lymphoma Study Association (LYSA), the Italian Foundation on Lymphoma (FIL) and the Carnot Institute for Lymphoma (CALYM). Forty scientific posters were presented. For the first time, specialists in the field of multiple myeloma (MM) were involved in the expert session. The aim was to establish from the experience of Italian and French studies new guidelines of FDG-PET/CT reporting for myeloma staging and restaging. The meeting dedicated an entire session to MM imaging followed by a session on the role of PET in Peripheral T cell Lymphoma. An entire session addressed the issues of Deauville scale particularly for end treatment assessment and the challenging consequences of immunomodulatory treatments on PET reporting. A specific session presented the potential role of baseline metabolic tumor measurement to predict outcome and identify different risk categories and the main results obtained in different lymphoma entities were described. Whether it could replace clinical staging has been extensively discussed. The more recent results obtained in the H10 trial have been presented and compared to the published data in early stage Hodgkin lymphoma. Finally, the ongoing studies using PET for guiding therapeutic strategies have been reported by the various lymphoma cooperative groups that participated to the meeting.
DOI: 10.1080/10428194.2017.1298752
PubMed: 28264597
Links to Exploration step
pubmed:28264597Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Report of the 6th International Workshop on PET in lymphoma.</title><author><name sortKey="Nanni, Cristina" sort="Nanni, Cristina" uniqKey="Nanni C" first="Cristina" last="Nanni">Cristina Nanni</name><affiliation><nlm:affiliation>a Nuclear Medicine and Hematology , University of Bologna , Bologna , Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Cottereau, Anne Segolene" sort="Cottereau, Anne Segolene" uniqKey="Cottereau A" first="Anne Ségolène" last="Cottereau">Anne Ségolène Cottereau</name><affiliation><nlm:affiliation>b Nuclear Medicine , Hôpital Tenon , Paris , France.</nlm:affiliation></affiliation></author><author><name sortKey="Lopci, Egesta" sort="Lopci, Egesta" uniqKey="Lopci E" first="Egesta" last="Lopci">Egesta Lopci</name><affiliation><nlm:affiliation>c Nuclear Medicine , Instituto Clinica Humanitas, IRCCS , Milano , Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Bodet Milin, Caroline" sort="Bodet Milin, Caroline" uniqKey="Bodet Milin C" first="Caroline" last="Bodet-Milin">Caroline Bodet-Milin</name><affiliation><nlm:affiliation>d Nuclear Medicine and Haematology , CHU Nantes , Nantes , France.</nlm:affiliation></affiliation></author><author><name sortKey="Coronado, Monica" sort="Coronado, Monica" uniqKey="Coronado M" first="Monica" last="Coronado">Monica Coronado</name><affiliation><nlm:affiliation>e Nuclear Medicine , La Paz University Hospital , Madrid , Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Pro, Barbara" sort="Pro, Barbara" uniqKey="Pro B" first="Barbara" last="Pro">Barbara Pro</name><affiliation><nlm:affiliation>f Hematology , Northwestern University Feinberg School of Medicine , Chicago , IL , USA.</nlm:affiliation></affiliation></author><author><name sortKey="Kim, Wong Seog" sort="Kim, Wong Seog" uniqKey="Kim W" first="Wong Seog" last="Kim">Wong Seog Kim</name><affiliation><nlm:affiliation>g Hematology , Samsung Medical Center , Seoul , Korea.</nlm:affiliation></affiliation></author><author><name sortKey="Trotman, Judith" sort="Trotman, Judith" uniqKey="Trotman J" first="Judith" last="Trotman">Judith Trotman</name><affiliation><nlm:affiliation>h Hematology , Concord Hospital, University of Sydney , Sydney , Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Barrington, Sally" sort="Barrington, Sally" uniqKey="Barrington S" first="Sally" last="Barrington">Sally Barrington</name><affiliation><nlm:affiliation>i PET Center, Guy's and St Thomas' Hospital, King's College , London , UK.</nlm:affiliation></affiliation></author><author><name sortKey="Duhrsen, Ulrich" sort="Duhrsen, Ulrich" uniqKey="Duhrsen U" first="Ulrich" last="Duhrsen">Ulrich Duhrsen</name><affiliation><nlm:affiliation>j Hematology , Universitätsklinikum , Essen , Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Vander Borght, Thierry" sort="Vander Borght, Thierry" uniqKey="Vander Borght T" first="Thierry" last="Vander Borght">Thierry Vander Borght</name><affiliation><nlm:affiliation>k Nuclear Medicine and Haematology , Université catholique de Louvain, CHU UCL Namur , Namur , Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Zamagni, Elena" sort="Zamagni, Elena" uniqKey="Zamagni E" first="Elena" last="Zamagni">Elena Zamagni</name><affiliation><nlm:affiliation>a Nuclear Medicine and Hematology , University of Bologna , Bologna , Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Kraeber Bodere, Francoise" sort="Kraeber Bodere, Francoise" uniqKey="Kraeber Bodere F" first="Françoise" last="Kraeber-Bodéré">Françoise Kraeber-Bodéré</name><affiliation><nlm:affiliation>d Nuclear Medicine and Haematology , CHU Nantes , Nantes , France.</nlm:affiliation></affiliation></author><author><name sortKey="Messiou, Christina" sort="Messiou, Christina" uniqKey="Messiou C" first="Christina" last="Messiou">Christina Messiou</name><affiliation><nlm:affiliation>l The Royal Marsden Hospital , London, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Rahmouni, Alain" sort="Rahmouni, Alain" uniqKey="Rahmouni A" first="Alain" last="Rahmouni">Alain Rahmouni</name><affiliation><nlm:affiliation>m Radiology, Lysa Imaging and Haematology , Hôpitaux Universitaires Henri Mondor , Créteil , France.</nlm:affiliation></affiliation></author><author><name sortKey="Buvat, Irene" sort="Buvat, Irene" uniqKey="Buvat I" first="Irène" last="Buvat">Irène Buvat</name><affiliation><nlm:affiliation>n Unité d'Imagerie Moléculaire in Vivo , Orsay , France.</nlm:affiliation></affiliation></author><author><name sortKey="Andre, Marc" sort="Andre, Marc" uniqKey="Andre M" first="Marc" last="Andre">Marc Andre</name><affiliation><nlm:affiliation>k Nuclear Medicine and Haematology , Université catholique de Louvain, CHU UCL Namur , Namur , Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Hertzberg, Mark" sort="Hertzberg, Mark" uniqKey="Hertzberg M" first="Mark" last="Hertzberg">Mark Hertzberg</name><affiliation><nlm:affiliation>o Haematology , Prince of Wales Hospital and Community Health Services , Sydney , Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Oyen, Wim" sort="Oyen, Wim" uniqKey="Oyen W" first="Wim" last="Oyen">Wim Oyen</name><affiliation><nlm:affiliation>l The Royal Marsden Hospital , London, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Casasnovas, Olivier" sort="Casasnovas, Olivier" uniqKey="Casasnovas O" first="Olivier" last="Casasnovas">Olivier Casasnovas</name><affiliation><nlm:affiliation>p Haematology , CHU Dijon , Dijon , France.</nlm:affiliation></affiliation></author><author><name sortKey="Luminari, Stefano" sort="Luminari, Stefano" uniqKey="Luminari S" first="Stefano" last="Luminari">Stefano Luminari</name><affiliation><nlm:affiliation>q Nuclear Medicine and Haematology , Arcispedale S. Maria Nuova, IRCCS , Reggio Emilia , Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Garderet, Laurent" sort="Garderet, Laurent" uniqKey="Garderet L" first="Laurent" last="Garderet">Laurent Garderet</name><affiliation><nlm:affiliation>r Haematology , Hôpital Saint Antoine , Paris , France.</nlm:affiliation></affiliation></author><author><name sortKey="Montravers, Francoise" sort="Montravers, Francoise" uniqKey="Montravers F" first="Françoise" last="Montravers">Françoise Montravers</name><affiliation><nlm:affiliation>b Nuclear Medicine , Hôpital Tenon , Paris , France.</nlm:affiliation></affiliation></author><author><name sortKey="Kobe, Carsten" sort="Kobe, Carsten" uniqKey="Kobe C" first="Carsten" last="Kobe">Carsten Kobe</name><affiliation><nlm:affiliation>s Nuclear Medicine , University Hospital of Cologne , Cologne , Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Kluge, Regine" sort="Kluge, Regine" uniqKey="Kluge R" first="Regine" last="Kluge">Regine Kluge</name><affiliation><nlm:affiliation>t Nuclear Medicine , University Hospital , Leipzig , Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Versari, Annibale" sort="Versari, Annibale" uniqKey="Versari A" first="Annibale" last="Versari">Annibale Versari</name><affiliation><nlm:affiliation>q Nuclear Medicine and Haematology , Arcispedale S. Maria Nuova, IRCCS , Reggio Emilia , Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Zucca, Emanuele" sort="Zucca, Emanuele" uniqKey="Zucca E" first="Emanuele" last="Zucca">Emanuele Zucca</name><affiliation><nlm:affiliation>u Haematology , Istituto Oncologico della Swizzera Italiana , Bellizona , Switzerland.</nlm:affiliation></affiliation></author><author><name sortKey="Moreau, Philippe" sort="Moreau, Philippe" uniqKey="Moreau P" first="Philippe" last="Moreau">Philippe Moreau</name><affiliation><nlm:affiliation>d Nuclear Medicine and Haematology , CHU Nantes , Nantes , France.</nlm:affiliation></affiliation></author><author><name sortKey="Cheson, Bruce" sort="Cheson, Bruce" uniqKey="Cheson B" first="Bruce" last="Cheson">Bruce Cheson</name><affiliation><nlm:affiliation>v Haematology , Lombardi Comprehensive Cancer Center , Washington , DC , USA.</nlm:affiliation></affiliation></author><author><name sortKey="Haioun, Corinne" sort="Haioun, Corinne" uniqKey="Haioun C" first="Corinne" last="Haioun">Corinne Haioun</name><affiliation><nlm:affiliation>m Radiology, Lysa Imaging and Haematology , Hôpitaux Universitaires Henri Mondor , Créteil , France.</nlm:affiliation></affiliation></author><author><name sortKey="Gallamini, Andrea" sort="Gallamini, Andrea" uniqKey="Gallamini A" first="Andrea" last="Gallamini">Andrea Gallamini</name><affiliation><nlm:affiliation>w Research, Innovation and Statistics Department, A. Lacassagne Cancer Center , Nice , France.</nlm:affiliation></affiliation></author><author><name sortKey="Meignan, Michel" sort="Meignan, Michel" uniqKey="Meignan M" first="Michel" last="Meignan">Michel Meignan</name><affiliation><nlm:affiliation>m Radiology, Lysa Imaging and Haematology , Hôpitaux Universitaires Henri Mondor , Créteil , France.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28264597</idno><idno type="pmid">28264597</idno><idno type="doi">10.1080/10428194.2017.1298752</idno><idno type="wicri:Area/PubMed/Corpus">000442</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000442</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Report of the 6th International Workshop on PET in lymphoma.</title><author><name sortKey="Nanni, Cristina" sort="Nanni, Cristina" uniqKey="Nanni C" first="Cristina" last="Nanni">Cristina Nanni</name><affiliation><nlm:affiliation>a Nuclear Medicine and Hematology , University of Bologna , Bologna , Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Cottereau, Anne Segolene" sort="Cottereau, Anne Segolene" uniqKey="Cottereau A" first="Anne Ségolène" last="Cottereau">Anne Ségolène Cottereau</name><affiliation><nlm:affiliation>b Nuclear Medicine , Hôpital Tenon , Paris , France.</nlm:affiliation></affiliation></author><author><name sortKey="Lopci, Egesta" sort="Lopci, Egesta" uniqKey="Lopci E" first="Egesta" last="Lopci">Egesta Lopci</name><affiliation><nlm:affiliation>c Nuclear Medicine , Instituto Clinica Humanitas, IRCCS , Milano , Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Bodet Milin, Caroline" sort="Bodet Milin, Caroline" uniqKey="Bodet Milin C" first="Caroline" last="Bodet-Milin">Caroline Bodet-Milin</name><affiliation><nlm:affiliation>d Nuclear Medicine and Haematology , CHU Nantes , Nantes , France.</nlm:affiliation></affiliation></author><author><name sortKey="Coronado, Monica" sort="Coronado, Monica" uniqKey="Coronado M" first="Monica" last="Coronado">Monica Coronado</name><affiliation><nlm:affiliation>e Nuclear Medicine , La Paz University Hospital , Madrid , Spain.</nlm:affiliation></affiliation></author><author><name sortKey="Pro, Barbara" sort="Pro, Barbara" uniqKey="Pro B" first="Barbara" last="Pro">Barbara Pro</name><affiliation><nlm:affiliation>f Hematology , Northwestern University Feinberg School of Medicine , Chicago , IL , USA.</nlm:affiliation></affiliation></author><author><name sortKey="Kim, Wong Seog" sort="Kim, Wong Seog" uniqKey="Kim W" first="Wong Seog" last="Kim">Wong Seog Kim</name><affiliation><nlm:affiliation>g Hematology , Samsung Medical Center , Seoul , Korea.</nlm:affiliation></affiliation></author><author><name sortKey="Trotman, Judith" sort="Trotman, Judith" uniqKey="Trotman J" first="Judith" last="Trotman">Judith Trotman</name><affiliation><nlm:affiliation>h Hematology , Concord Hospital, University of Sydney , Sydney , Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Barrington, Sally" sort="Barrington, Sally" uniqKey="Barrington S" first="Sally" last="Barrington">Sally Barrington</name><affiliation><nlm:affiliation>i PET Center, Guy's and St Thomas' Hospital, King's College , London , UK.</nlm:affiliation></affiliation></author><author><name sortKey="Duhrsen, Ulrich" sort="Duhrsen, Ulrich" uniqKey="Duhrsen U" first="Ulrich" last="Duhrsen">Ulrich Duhrsen</name><affiliation><nlm:affiliation>j Hematology , Universitätsklinikum , Essen , Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Vander Borght, Thierry" sort="Vander Borght, Thierry" uniqKey="Vander Borght T" first="Thierry" last="Vander Borght">Thierry Vander Borght</name><affiliation><nlm:affiliation>k Nuclear Medicine and Haematology , Université catholique de Louvain, CHU UCL Namur , Namur , Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Zamagni, Elena" sort="Zamagni, Elena" uniqKey="Zamagni E" first="Elena" last="Zamagni">Elena Zamagni</name><affiliation><nlm:affiliation>a Nuclear Medicine and Hematology , University of Bologna , Bologna , Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Kraeber Bodere, Francoise" sort="Kraeber Bodere, Francoise" uniqKey="Kraeber Bodere F" first="Françoise" last="Kraeber-Bodéré">Françoise Kraeber-Bodéré</name><affiliation><nlm:affiliation>d Nuclear Medicine and Haematology , CHU Nantes , Nantes , France.</nlm:affiliation></affiliation></author><author><name sortKey="Messiou, Christina" sort="Messiou, Christina" uniqKey="Messiou C" first="Christina" last="Messiou">Christina Messiou</name><affiliation><nlm:affiliation>l The Royal Marsden Hospital , London, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Rahmouni, Alain" sort="Rahmouni, Alain" uniqKey="Rahmouni A" first="Alain" last="Rahmouni">Alain Rahmouni</name><affiliation><nlm:affiliation>m Radiology, Lysa Imaging and Haematology , Hôpitaux Universitaires Henri Mondor , Créteil , France.</nlm:affiliation></affiliation></author><author><name sortKey="Buvat, Irene" sort="Buvat, Irene" uniqKey="Buvat I" first="Irène" last="Buvat">Irène Buvat</name><affiliation><nlm:affiliation>n Unité d'Imagerie Moléculaire in Vivo , Orsay , France.</nlm:affiliation></affiliation></author><author><name sortKey="Andre, Marc" sort="Andre, Marc" uniqKey="Andre M" first="Marc" last="Andre">Marc Andre</name><affiliation><nlm:affiliation>k Nuclear Medicine and Haematology , Université catholique de Louvain, CHU UCL Namur , Namur , Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Hertzberg, Mark" sort="Hertzberg, Mark" uniqKey="Hertzberg M" first="Mark" last="Hertzberg">Mark Hertzberg</name><affiliation><nlm:affiliation>o Haematology , Prince of Wales Hospital and Community Health Services , Sydney , Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Oyen, Wim" sort="Oyen, Wim" uniqKey="Oyen W" first="Wim" last="Oyen">Wim Oyen</name><affiliation><nlm:affiliation>l The Royal Marsden Hospital , London, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Casasnovas, Olivier" sort="Casasnovas, Olivier" uniqKey="Casasnovas O" first="Olivier" last="Casasnovas">Olivier Casasnovas</name><affiliation><nlm:affiliation>p Haematology , CHU Dijon , Dijon , France.</nlm:affiliation></affiliation></author><author><name sortKey="Luminari, Stefano" sort="Luminari, Stefano" uniqKey="Luminari S" first="Stefano" last="Luminari">Stefano Luminari</name><affiliation><nlm:affiliation>q Nuclear Medicine and Haematology , Arcispedale S. Maria Nuova, IRCCS , Reggio Emilia , Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Garderet, Laurent" sort="Garderet, Laurent" uniqKey="Garderet L" first="Laurent" last="Garderet">Laurent Garderet</name><affiliation><nlm:affiliation>r Haematology , Hôpital Saint Antoine , Paris , France.</nlm:affiliation></affiliation></author><author><name sortKey="Montravers, Francoise" sort="Montravers, Francoise" uniqKey="Montravers F" first="Françoise" last="Montravers">Françoise Montravers</name><affiliation><nlm:affiliation>b Nuclear Medicine , Hôpital Tenon , Paris , France.</nlm:affiliation></affiliation></author><author><name sortKey="Kobe, Carsten" sort="Kobe, Carsten" uniqKey="Kobe C" first="Carsten" last="Kobe">Carsten Kobe</name><affiliation><nlm:affiliation>s Nuclear Medicine , University Hospital of Cologne , Cologne , Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Kluge, Regine" sort="Kluge, Regine" uniqKey="Kluge R" first="Regine" last="Kluge">Regine Kluge</name><affiliation><nlm:affiliation>t Nuclear Medicine , University Hospital , Leipzig , Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Versari, Annibale" sort="Versari, Annibale" uniqKey="Versari A" first="Annibale" last="Versari">Annibale Versari</name><affiliation><nlm:affiliation>q Nuclear Medicine and Haematology , Arcispedale S. Maria Nuova, IRCCS , Reggio Emilia , Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Zucca, Emanuele" sort="Zucca, Emanuele" uniqKey="Zucca E" first="Emanuele" last="Zucca">Emanuele Zucca</name><affiliation><nlm:affiliation>u Haematology , Istituto Oncologico della Swizzera Italiana , Bellizona , Switzerland.</nlm:affiliation></affiliation></author><author><name sortKey="Moreau, Philippe" sort="Moreau, Philippe" uniqKey="Moreau P" first="Philippe" last="Moreau">Philippe Moreau</name><affiliation><nlm:affiliation>d Nuclear Medicine and Haematology , CHU Nantes , Nantes , France.</nlm:affiliation></affiliation></author><author><name sortKey="Cheson, Bruce" sort="Cheson, Bruce" uniqKey="Cheson B" first="Bruce" last="Cheson">Bruce Cheson</name><affiliation><nlm:affiliation>v Haematology , Lombardi Comprehensive Cancer Center , Washington , DC , USA.</nlm:affiliation></affiliation></author><author><name sortKey="Haioun, Corinne" sort="Haioun, Corinne" uniqKey="Haioun C" first="Corinne" last="Haioun">Corinne Haioun</name><affiliation><nlm:affiliation>m Radiology, Lysa Imaging and Haematology , Hôpitaux Universitaires Henri Mondor , Créteil , France.</nlm:affiliation></affiliation></author><author><name sortKey="Gallamini, Andrea" sort="Gallamini, Andrea" uniqKey="Gallamini A" first="Andrea" last="Gallamini">Andrea Gallamini</name><affiliation><nlm:affiliation>w Research, Innovation and Statistics Department, A. Lacassagne Cancer Center , Nice , France.</nlm:affiliation></affiliation></author><author><name sortKey="Meignan, Michel" sort="Meignan, Michel" uniqKey="Meignan M" first="Michel" last="Meignan">Michel Meignan</name><affiliation><nlm:affiliation>m Radiology, Lysa Imaging and Haematology , Hôpitaux Universitaires Henri Mondor , Créteil , France.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Leukemia & lymphoma</title><idno type="eISSN">1029-2403</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Two hundred and ten nuclear medicine physicians, radiologists, and hematologists from 26 countries attended the 6th International Workshop on Positron Emission Tomography (PET) in Lymphoma and Myeloma held in Menton, France, in September 2016. The meeting was under the auspices of the European Lymphoma Institute (ELI), the European Association of Nuclear Medicine (EANM) the Lymphoma Study Association (LYSA), the Italian Foundation on Lymphoma (FIL) and the Carnot Institute for Lymphoma (CALYM). Forty scientific posters were presented. For the first time, specialists in the field of multiple myeloma (MM) were involved in the expert session. The aim was to establish from the experience of Italian and French studies new guidelines of FDG-PET/CT reporting for myeloma staging and restaging. The meeting dedicated an entire session to MM imaging followed by a session on the role of PET in Peripheral T cell Lymphoma. An entire session addressed the issues of Deauville scale particularly for end treatment assessment and the challenging consequences of immunomodulatory treatments on PET reporting. A specific session presented the potential role of baseline metabolic tumor measurement to predict outcome and identify different risk categories and the main results obtained in different lymphoma entities were described. Whether it could replace clinical staging has been extensively discussed. The more recent results obtained in the H10 trial have been presented and compared to the published data in early stage Hodgkin lymphoma. Finally, the ongoing studies using PET for guiding therapeutic strategies have been reported by the various lymphoma cooperative groups that participated to the meeting.</div></front></TEI><pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">28264597</PMID><DateCreated><Year>2017</Year><Month>03</Month><Day>07</Day></DateCreated><DateRevised><Year>2017</Year><Month>06</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1029-2403</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>10</Issue><PubDate><Year>2017</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Leukemia & lymphoma</Title><ISOAbbreviation>Leuk. Lymphoma</ISOAbbreviation></Journal><ArticleTitle>Report of the 6th International Workshop on PET in lymphoma.</ArticleTitle><Pagination><MedlinePgn>2298-2303</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/10428194.2017.1298752</ELocationID><Abstract><AbstractText>Two hundred and ten nuclear medicine physicians, radiologists, and hematologists from 26 countries attended the 6th International Workshop on Positron Emission Tomography (PET) in Lymphoma and Myeloma held in Menton, France, in September 2016. The meeting was under the auspices of the European Lymphoma Institute (ELI), the European Association of Nuclear Medicine (EANM) the Lymphoma Study Association (LYSA), the Italian Foundation on Lymphoma (FIL) and the Carnot Institute for Lymphoma (CALYM). Forty scientific posters were presented. For the first time, specialists in the field of multiple myeloma (MM) were involved in the expert session. The aim was to establish from the experience of Italian and French studies new guidelines of FDG-PET/CT reporting for myeloma staging and restaging. The meeting dedicated an entire session to MM imaging followed by a session on the role of PET in Peripheral T cell Lymphoma. An entire session addressed the issues of Deauville scale particularly for end treatment assessment and the challenging consequences of immunomodulatory treatments on PET reporting. A specific session presented the potential role of baseline metabolic tumor measurement to predict outcome and identify different risk categories and the main results obtained in different lymphoma entities were described. Whether it could replace clinical staging has been extensively discussed. The more recent results obtained in the H10 trial have been presented and compared to the published data in early stage Hodgkin lymphoma. Finally, the ongoing studies using PET for guiding therapeutic strategies have been reported by the various lymphoma cooperative groups that participated to the meeting.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nanni</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>a Nuclear Medicine and Hematology , University of Bologna , Bologna , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cottereau</LastName><ForeName>Anne Ségolène</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>b Nuclear Medicine , Hôpital Tenon , Paris , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopci</LastName><ForeName>Egesta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>c Nuclear Medicine , Instituto Clinica Humanitas, IRCCS , Milano , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bodet-Milin</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>d Nuclear Medicine and Haematology , CHU Nantes , Nantes , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coronado</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>e Nuclear Medicine , La Paz University Hospital , Madrid , Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pro</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>f Hematology , Northwestern University Feinberg School of Medicine , Chicago , IL , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Wong Seog</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>g Hematology , Samsung Medical Center , Seoul , Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trotman</LastName><ForeName>Judith</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>h Hematology , Concord Hospital, University of Sydney , Sydney , Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrington</LastName><ForeName>Sally</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>i PET Center, Guy's and St Thomas' Hospital, King's College , London , UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duhrsen</LastName><ForeName>Ulrich</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>j Hematology , Universitätsklinikum , Essen , Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vander Borght</LastName><ForeName>Thierry</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>k Nuclear Medicine and Haematology , Université catholique de Louvain, CHU UCL Namur , Namur , Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zamagni</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>a Nuclear Medicine and Hematology , University of Bologna , Bologna , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kraeber-Bodéré</LastName><ForeName>Françoise</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>d Nuclear Medicine and Haematology , CHU Nantes , Nantes , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messiou</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>l The Royal Marsden Hospital , London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahmouni</LastName><ForeName>Alain</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>m Radiology, Lysa Imaging and Haematology , Hôpitaux Universitaires Henri Mondor , Créteil , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buvat</LastName><ForeName>Irène</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>n Unité d'Imagerie Moléculaire in Vivo , Orsay , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andre</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>k Nuclear Medicine and Haematology , Université catholique de Louvain, CHU UCL Namur , Namur , Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hertzberg</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>o Haematology , Prince of Wales Hospital and Community Health Services , Sydney , Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oyen</LastName><ForeName>Wim</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>l The Royal Marsden Hospital , London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casasnovas</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>p Haematology , CHU Dijon , Dijon , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luminari</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>q Nuclear Medicine and Haematology , Arcispedale S. Maria Nuova, IRCCS , Reggio Emilia , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garderet</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>r Haematology , Hôpital Saint Antoine , Paris , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montravers</LastName><ForeName>Françoise</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>b Nuclear Medicine , Hôpital Tenon , Paris , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kobe</LastName><ForeName>Carsten</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>s Nuclear Medicine , University Hospital of Cologne , Cologne , Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kluge</LastName><ForeName>Regine</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>t Nuclear Medicine , University Hospital , Leipzig , Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Versari</LastName><ForeName>Annibale</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>q Nuclear Medicine and Haematology , Arcispedale S. Maria Nuova, IRCCS , Reggio Emilia , Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zucca</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>u Haematology , Istituto Oncologico della Swizzera Italiana , Bellizona , Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreau</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>d Nuclear Medicine and Haematology , CHU Nantes , Nantes , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheson</LastName><ForeName>Bruce</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>v Haematology , Lombardi Comprehensive Cancer Center , Washington , DC , USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haioun</LastName><ForeName>Corinne</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>m Radiology, Lysa Imaging and Haematology , Hôpitaux Universitaires Henri Mondor , Créteil , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallamini</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>w Research, Innovation and Statistics Department, A. Lacassagne Cancer Center , Nice , France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meignan</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>m Radiology, Lysa Imaging and Haematology , Hôpitaux Universitaires Henri Mondor , Créteil , France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Leuk Lymphoma</MedlineTA><NlmUniqueID>9007422</NlmUniqueID><ISSNLinking>1026-8022</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PET</Keyword><Keyword MajorTopicYN="N">lymphoma</Keyword><Keyword MajorTopicYN="N">myeloma</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28264597</ArticleId><ArticleId IdType="doi">10.1080/10428194.2017.1298752</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000442 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000442 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:28264597
|texte= Report of the 6th International Workshop on PET in lymphoma.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:28264597" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |